## CBOE: Cboe Global Markets, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG 2.09 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($237.03)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Cboe Global Markets (CBOE) Valuation After Barclays Upgrade on Derivatives Growth and Strategic Refocus**
- Source: Simply Wall Street | 20251216T140119 | Somewhat-Bullish | Relevance: 100%
- Barclays upgraded Cboe Global Markets (CBOE) to Overweight, citing its strong index options engine, increased retail options activity, and a sharpened focus on core derivatives. Despite a strong performance year-to-date and near-record highs, the stock's valuation is a key debate, showing a narrative fair value of $262.08 (moderately undervalued) versus a DCF model's $201 (overvalued). The narrative emphasizes Cboe's double-digit revenue growth in Data Vantage and operational efficiencies, while the DCF model suggests potential overvaluation if growth or margins underperform.

**2. How Investors Are Reacting To Cboe Global Markets (CBOE) Barclays Upgrade And 24-Hour Russell 2000 Options**
- Source: Simply Wall Street | 20251214T150759 | Somewhat-Bullish | Relevance: 100%
- Barclays recently upgraded Cboe Global Markets to Overweight, citing strong growth in index options and retail options activity, alongside a focus on core derivatives. Cboe also plans to extend Russell 2000 Index options to nearly 24-hour trading by February 2026, enhancing access to its proprietary index products. These developments reinforce Cboe's growth narrative, although investors should consider its concentration risk in core index franchises and potential fee pressures.

**3. Thrivent Financial for Lutherans Has $27.24 Million Position in Cboe Global Markets, Inc. $CBOE**
- Source: MarketBeat | 20251216T135219 | Neutral | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Cboe Global Markets, Inc. (NASDAQ:CBOE) by 44.3% in the second quarter, now owning 116,859 shares valued at $27.24 million. This move comes as Cboe Global Markets reported strong quarterly earnings, beating consensus estimates with an EPS of $2.67 and a 13.8% year-over-year revenue increase. The company also recently paid a quarterly dividend of $0.72 per share, and analysts maintain a "Hold" rating with an average target price of $245.15 for the stock.

**4. Cboe Global Markets, Inc. $CBOE Shares Sold by Gilder Gagnon Howe & Co. LLC**
- Source: MarketBeat | 20251213T114753 | Somewhat-Bullish | Relevance: 100%
- Gilder Gagnon Howe & Co. LLC reduced its stake in Cboe Global Markets, Inc. (NASDAQ:CBOE) by 9.9% in the second quarter, selling over 25,000 shares. Despite this, other institutional investors like Alliancebernstein L.P. and Norges Bank significantly increased their holdings. Wall Street analysts have provided varied ratings for CBOE, with a consensus "Hold" rating and an average price target of $245.15.

**5. Coppell Advisory Solutions LLC Makes New $4.91 Million Investment in Cboe Global Markets, Inc. $CBOE**
- Source: MarketBeat | 20251214T101418 | Bullish | Relevance: 98%
- Coppell Advisory Solutions LLC recently invested $4.91 million in Cboe Global Markets, acquiring 21,424 shares during the second quarter. Despite several brokerages increasing their price targets, the stock maintains a "Hold" consensus rating with an average target of $245.15. Cboe Global Markets exceeded quarterly earnings estimates and declared a $0.72 per-share dividend.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $302 | $273 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 9.0% (-2.7%)
- Alliancebernstein L.: 6.1% (-31.2%)
- State Street Corpora: 4.5% (+2.1%)
- FMR, LLC: 4.3% (+62.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Forward P/E 22.7x stretched relative to 5% growth. Quality metrics strong (ROE 22%, margin 21%). Analyst sentiment positive (1 raises, avg +11%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.8B |
| Beta | 0.35 |
| 52W Range | $187.30 - $262.98 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 22.7 |
| Current P/E | 23.8 |
| YoY Growth | 4.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -1.5% to -0.5% (+1.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). Underperforming sector by 4.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.05x) but short-term weakness (below SMA20). MACD histogram bearish (-1.25), momentum weakening. RSI neutral at 40. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.47% (CS: 23) | Neutral |
| RSI_14 | 40.5 | Neutral |
| MACD Histogram | -1.25 | Bearish |
| vs SMA20 | 0.971x | Below |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 1.053x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $246.75
- **Stop Loss:** $237.03 (3.9% risk)
- **Target:** $256.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 123
- **Position Value:** $30,350.25
- **Portfolio %:** 30.35%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-06 (Est: $2.73)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.53 | $2.67 | +5.6% |
| 2025Q2 | $2.44 | $2.46 | +0.6% |
| 2025Q1 | $2.36 | $2.50 | +5.8% |
| 2024Q4 | $2.12 | $2.10 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*